Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank80
3Y CAGR+1.2%
5Y CAGR+100.8%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+1.2%/yr
Annual compound
5Y CAGR
+100.8%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
32.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$238.99M-22.9%
2023$310.13M+57.8%
2022$196.59M-14.6%
2021$230.33M+418.4%
2020$44.43M+506.8%
2019$7.32M-